Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 537,000 | 475,000 | 647,000 | 444,000 | 273,000 |
| General And Administrative Expense | 537,000 | 475,000 | 647,000 | 444,000 | 273,000 |
| Research And Development | 391,000 | -- | 906,000 | 848,000 | 1.3M |
| Other Operating Expenses | -- | -- | 541,000 | 422,000 | 245,000 |
| Operating Expense | 928,000 | -- | 1.6M | 1.3M | 1.6M |
| Operating Income | -928,000 | -- | -1.6M | -1.3M | -1.6M |
| EBIT | -997,000 | -- | -1.5M | -1.4M | -1.3M |
| Interest Expense | 11,000 | -- | 1,000 | 3,000 | 1,000 |
| Interest Expense Non Operating | 11,000 | -- | 1,000 | 3,000 | 1,000 |
| Interest Income | 2,000 | -- | 8,000 | 2,000 | 7,000 |
| Interest Income Non Operating | 2,000 | -- | 8,000 | 2,000 | 7,000 |
| Net Interest Income | -9,000 | -- | 7,000 | -1,000 | 6,000 |
| Other Income Expense | -71,000 | -- | 2,000 | -82,000 | 252,000 |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 268,000 |
| Special Income Charges | 0.00 | -- | -2,000 | 13,000 | 6,000 |
| Gain On Sale Of Security | -71,000 | -- | 4,000 | -95,000 | -22,000 |
| Pretax Income | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Tax Effect Of Unusual Items | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Income From Continuing Operation Net Minority Interest | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Income Including Noncontrolling Interests | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Income Common Stockholders | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Income | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| EBITDA | -995,000 | -- | -1.5M | -1.4M | -1.3M |
| Normalized EBITDA | -924,000 | -- | -1.5M | -1.3M | -1.3M |
| Reconciled Depreciation | 2,000 | -- | 3,000 | 2,000 | 4,000 |
| Basic EPS | -0.01 | -- | -0.03 | -0.03 | -0.03 |
| Diluted EPS | -0.01 | -- | -0.03 | -0.03 | -0.03 |
| Basic Average Shares | 75.9M | -- | 53.0M | 50.1M | 49.0M |
| Diluted Average Shares | 75.9M | -- | 53.0M | 50.1M | 49.0M |
| Total Unusual Items | -71,000 | -- | 2,000 | -82,000 | -16,000 |
| Total Unusual Items Excluding Goodwill | -71,000 | -- | 2,000 | -82,000 | -16,000 |
| Tax Rate For Calcs | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Normalized Income | -937,000 | -- | -1.5M | -1.3M | -1.3M |
| Diluted NI Availto Com Stockholders | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Gain On Sale Of Ppe | 0.00 | -- | -2,000 | 13,000 | 6,000 |
| Net Income Continuous Operations | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Non Operating Interest Income Expense | -9,000 | -- | 7,000 | -1,000 | 6,000 |
| Other Gand A | 401,000 | 333,000 | 541,000 | 422,000 | 245,000 |
| Other Special Charges | -- | -- | -- | -- | -268,000 |
| Salaries And Wages | 136,000 | -- | 106,000 | 22,000 | 28,000 |
| Total Expenses | 928,000 | -- | 1.6M | 1.3M | 1.6M |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 498,000 | -- | 715,000 | 2.0M | 228,000 |
| Cash Cash Equivalents And Short Term Investments | 498,000 | -- | 715,000 | 2.0M | 228,000 |
| Cash Financial | 498,000 | -- | 715,000 | 2.0M | 228,000 |
| Receivables | 177,000 | -- | 287,000 | 236,000 | 176,000 |
| Prepaid Assets | -- | -- | -- | -- | -- |
| Current Assets | 675,000 | -- | 1.0M | 2.2M | 404,000 |
| Gross PPE | 1.2M | -- | 1.2M | 1.2M | 1.3M |
| Accumulated Depreciation | -1.2M | -- | -1.2M | -1.2M | -1.3M |
| Net PPE | 2,000 | -- | 7,000 | 10,000 | 10,000 |
| Goodwill And Other Intangible Assets | 18.4M | -- | -- | -- | -- |
| Total Non Current Assets | 18.4M | -- | 7,000 | 10,000 | 10,000 |
| Total Assets | 19.1M | -- | 1.0M | 2.2M | 414,000 |
| Current Debt | 352,000 | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 352,000 | -- | -- | -- | -- |
| Accounts Payable | 2.1M | -- | 1.8M | 1.4M | 988,000 |
| Payables | 2.1M | -- | 1.8M | 1.4M | 988,000 |
| Payables And Accrued Expenses | 2.6M | -- | 2.4M | 2.3M | 1.8M |
| Current Accrued Expenses | 586,000 | -- | 617,000 | 821,000 | 790,000 |
| Current Liabilities | 3.0M | -- | 2.4M | 2.3M | 1.8M |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 3.0M | -- | 2.4M | 2.3M | 1.8M |
| Common Stock | 180.8M | -- | 161.4M | 161.3M | 158.6M |
| Capital Stock | 180.8M | -- | 161.4M | 161.3M | 158.6M |
| Additional Paid In Capital | 48.3M | -- | 48.3M | 47.3M | 46.8M |
| Retained Earnings | -216.9M | -- | -214.9M | -213.4M | -212.0M |
| Common Stock Equity | 16.1M | -- | -1.4M | -19,000 | -1.4M |
| Stockholders Equity | 16.1M | -- | -1.4M | -19,000 | -1.4M |
| Total Equity Gross Minority Interest | 16.1M | -- | -1.4M | -19,000 | -1.4M |
| Total Capitalization | 16.1M | -- | -1.4M | -19,000 | -1.4M |
| Net Tangible Assets | -2.3M | -- | -1.4M | -19,000 | -1.4M |
| Tangible Book Value | -2.3M | -- | -1.4M | -19,000 | -1.4M |
| Working Capital | -2.3M | -- | -1.4M | -29,000 | -1.4M |
| Invested Capital | 16.4M | -- | -1.4M | -19,000 | -1.4M |
| Total Debt | 352,000 | -- | -- | -- | -- |
| Share Issued | 76.4M | -- | 53.1M | 53.0M | 49.0M |
| Ordinary Shares Number | 76.4M | -- | 53.1M | 53.0M | 49.0M |
| Leases | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Machinery Furniture Equipment | 105,000 | -- | 105,000 | 106,000 | 104,000 |
| Other Equity Interest | 3.9M | -- | 3.9M | 4.8M | 5.2M |
| Other Properties | 1.1M | -- | 1.1M | 1.1M | 1.2M |
| Other Receivables | 153,000 | -- | 270,000 | 217,000 | 155,000 |
| Properties | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Taxes Receivable | 24,000 | -- | 17,000 | 19,000 | 21,000 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.2M | -- | -1.4M | -940,000 | -861,000 |
| Cash Flow From Continuing Operating Activities | -1.2M | -- | -1.4M | -940,000 | -861,000 |
| Depreciation And Amortization | 2,000 | -- | 3,000 | 2,000 | 4,000 |
| Depreciation Amortization Depletion | 2,000 | -- | 3,000 | 2,000 | 4,000 |
| Stock Based Compensation | 0.00 | -- | 60,000 | 35,000 | 62,000 |
| Deferred Tax | 15,000 | -- | -- | -- | 0.00 |
| Deferred Income Tax | 15,000 | -- | -- | -- | 0.00 |
| Change In Working Capital | -306,000 | -- | 102,000 | 302,000 | 675,000 |
| Changes In Account Receivables | 67,000 | -- | 2,000 | 2,000 | 18,000 |
| Change In Receivables | 67,000 | -- | 2,000 | 2,000 | 18,000 |
| Change In Payables And Accrued Expense | -458,000 | -- | 153,000 | 362,000 | 476,000 |
| Change In Other Current Liabilities | -- | -- | 0.00 | 0.00 | 0.00 |
| Other Non Cash Items | 4,000 | -- | 0.00 | 0.00 | -268,000 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Purchase Of PPE | -- | -- | 0.00 | -2,000 | 0.00 |
| Net PPE Purchase And Sale | 0.00 | -- | 0.00 | 9,000 | 8,000 |
| Investing Cash Flow | 0.00 | -- | 0.00 | 9,000 | 8,000 |
| Cash Flow From Continuing Investing Activities | 0.00 | -- | 0.00 | 9,000 | 8,000 |
| Repayment Of Debt | -- | -- | -- | -- | -- |
| Net Issuance Payments Of Debt | -- | -- | -- | -- | -- |
| Issuance Of Capital Stock | 1.7M | -- | 100,000 | 2.7M | 0.00 |
| Net Common Stock Issuance | 1.7M | -- | 100,000 | 2.7M | 0.00 |
| Financing Cash Flow | 1.7M | -- | 100,000 | 2.7M | 0.00 |
| Cash Flow From Continuing Financing Activities | 1.7M | -- | 100,000 | 2.7M | 0.00 |
| Effect Of Exchange Rate Changes | -- | -- | 0.00 | 0.00 | 0.00 |
| Changes In Cash | 433,000 | -- | -1.3M | 1.8M | -853,000 |
| Beginning Cash Position | 65,000 | -- | 2.0M | 228,000 | 1.1M |
| End Cash Position | 498,000 | -- | 715,000 | 2.0M | 228,000 |
| Free Cash Flow | -1.2M | -- | -1.4M | -942,000 | -861,000 |
| Interest Paid Supplemental Data | 1,000 | -- | -- | -- | 0.00 |
| Change In Prepaid Assets | 85,000 | -- | -53,000 | -62,000 | 181,000 |
| Common Stock Issuance | 1.7M | -- | 100,000 | 2.7M | 0.00 |
| Depreciation | 2,000 | -- | 3,000 | 2,000 | 4,000 |
| Gain Loss On Sale Of PPE | 0.00 | -- | 2,000 | -13,000 | -6,000 |
| Net Foreign Currency Exchange Gain Loss | 71,000 | -- | -4,000 | 109,000 | 8,000 |
| Net Income From Continuing Operations | -1.0M | -- | -1.5M | -1.4M | -1.3M |
| Net Short Term Debt Issuance | -- | -- | -- | -- | -- |
| Operating Gains Losses | 71,000 | -- | -2,000 | 96,000 | 2,000 |
| Sale Of PPE | 0.00 | -- | 0.00 | 11,000 | 8,000 |
| Short Term Debt Payments | -- | -- | -- | -- | -- |